Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

PIETRO PEPE; GIUSEPPE DIBENEDETTO; LUDOVICA PEPE; MICHELE PENNISI

doi:10.21873/invivo.11786

Research ArticleClinical Studies

Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

PIETRO PEPE, GIUSEPPE DIBENEDETTO, LUDOVICA PEPE and MICHELE PENNISI

In Vivo January 2020, 34 (1) 393-396; DOI: https://doi.org/10.21873/invivo.11786

PIETRO PEPE

Urology Unit, Cannizzaro Hospital, Catania, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: piepepe@hotmail.com

GIUSEPPE DIBENEDETTO

Urology Unit, Cannizzaro Hospital, Catania, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

LUDOVICA PEPE

Urology Unit, Cannizzaro Hospital, Catania, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MICHELE PENNISI

Urology Unit, Cannizzaro Hospital, Catania, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 34 no. 1 393-396

DOI

https://doi.org/10.21873/invivo.11786

PubMed

31882504

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received September 15, 2019
Revision received November 2, 2019
Accepted November 4, 2019
Published online December 27, 2019.

Author Information

PIETRO PEPE⇑,
GIUSEPPE DIBENEDETTO,
LUDOVICA PEPE and
MICHELE PENNISI

Urology Unit, Cannizzaro Hospital, Catania, Italy

Correspondence to: Pietro Pepe, MD, Urology Unit, Cannizzaro Hospital, Via Messina 829, Catania, Italy. Tel: + 39 957263285, Fax: + 39 957263259, e-mail: piepepe{at}hotmail.com

View Full Text

Statistics from Altmetric.com

Cited By...

25 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Stefano Salciccia, Anna Laura Capriotti, Aldo Laganà, Stefano Fais, Mariantonia Logozzi, Ettore De Berardinis, Gian Maria Busetto, Giovanni Battista Di Pierro, Gian Piero Ricciuti, Francesco Del Giudice, Alessandro Sciarra, Peter R. Carroll, Matthew R. Cooperberg, Beatrice Sciarra, Martina Maggi

International Journal of Molecular Sciences 2021 22 9
Biomarkers of Aggressive Prostate Cancer at Diagnosis

Brock E. Boehm, Monica E. York, Gyorgy Petrovics, Indu Kohaar, Gregory T. Chesnut

International Journal of Molecular Sciences 2023 24 3
Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy

Gian Maria Busetto, Francesco Del Giudice, Martina Maggi, Ferdinando De Marco, Angelo Porreca, Isabella Sperduti, Fabio Massimo Magliocca, Stefano Salciccia, Benjamin I. Chung, Ettore De Berardinis, Alessandro Sciarra

World Journal of Urology 2021 39 6
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer

Pietro Pepe, Ludovica Pepe, Maria Tamburo, Giulia Marletta, Michele Pennisi, Filippo Fraggetta

Archivio Italiano di Urologia e Andrologia 2022 94 3
Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice

Belén Pastor-Navarro, José Rubio-Briones, Ángel Borque-Fernando, Luis M. Esteban, Jose Luis Dominguez-Escrig, José Antonio López-Guerrero

International Journal of Molecular Sciences 2021 22 12
Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Duncan McLaren, Arran K. Turnbull

Journal of Personalized Medicine 2021 11 7
Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis

Reza Sari Motlagh, Takafumi Yanagisawa, Tatsushi Kawada, Ekaterina Laukhtina, Pawel Rajwa, Abdulmajeed Aydh, Frederik König, Maximilan Pallauf, Nicolai A. Huebner, Pascal A. Baltzer, Pierre I. Karakiewicz, Axel Heidenreich, Shahrokh F. Shariat

Prostate Cancer and Prostatic Diseases 2022 25 2
mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: Our experience in 950 cases

Pietro Pepe, Giuseppe Candiano, Ludovica Pepe, Michele Pennisi, Filippo Fraggetta

Archivio Italiano di Urologia e Andrologia 2021 93 2
The utility of prostate MRI within active surveillance: description of the evidence

Georgina Dominique, Wayne G. Brisbane, Robert E. Reiter

World Journal of Urology 2022 40 1
A risk model for detecting clinically significant prostate cancer based on bi-parametric magnetic resonance imaging in a Japanese cohort

Kazushige Sakaguchi, Michikata Hayashida, Naoto Tanaka, Suguru Oka, Shinji Urakami

Scientific Reports 2021 11 1
Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?

Mohammad Sajjad Rahnama'i, Christian Bach, Maximilian Schulze‐Hagen, Christiane K Kuhl, Thomas Alexander Vögeli

Cancer Reports 2021 4 6
Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer

Marcelino Yazbek Hanna, Mark Winterbone, Shea P. O’Connell, Mireia Olivan, Rachel Hurst, Rob Mills, Colin S. Cooper, Daniel S. Brewer, Jeremy Clark

Cancers 2023 15 3
Papel de PCA3 y SelectMDx en la optimización de la vigilancia activa en el cáncer de próstata

D. Fiorella, J.L. Marenco, J.M. Mascarós, A. Borque-Fernando, L.M. Esteban, A. Calatrava, B. Pastor, J.A. López-Guerrero, J. Rubio-Briones

Actas Urológicas Españolas 2021 45 6
An up-to-date catalogue of urinary markers for the management of prostate cancer

Stephan Brönimann, Benjamin Pradere, Pierre Karakiewicz, Nicolai A. Huebner, Alberto Briganti, Shahrokh F. Shariat

Current Opinion in Urology 2020 30 5
Conﬁrmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassiﬁcation rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy

Pietro Pepe, Ludovica Pepe, Michele Pennisi, Filippo Fraggetta

Archivio Italiano di Urologia e Andrologia 2022 94 3
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients

Jinan Guo, Xuhui Zhang, Taolin Xia, Heather Johnson, Xiaoyan Feng, Athanasios Simoulis, Alan H. B. Wu, Fei Li, Wanlong Tan, Allan Johnson, Nishtman Dizeyi, Per-Anders Abrahamsson, Lukas Kenner, Kefeng Xiao, Heqiu Zhang, Lingwu Chen, Chang Zou, Jenny L. Persson

Frontiers in Medicine 2021 8
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance

Joseba Salguero, Enrique Gómez-Gómez, José Valero-Rosa, Julia Carrasco-Valiente, Juan Mesa, Cristina Martin, Juan Pablo Campos-Hernández, Juan Manuel Rubio, Daniel López, María José Requena

Korean Journal of Radiology 2021 22 4
Role of PCA3 and SelectMDx in the optimization of active surveillance in prostate cancer

D. Fiorella, J.L. Marenco, J.M. Mascarós, Á. Borque-Fernando, L.M. Esteban, A. Calatrava, B. Pastor, J.A. López-Guerrero, J. Rubio-Briones

Actas Urológicas Españolas (English Edition) 2021 45 6
Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review

Elizabeth E. Ellis, Thomas P. Frye

Therapeutic Advances in Urology 2022 14
68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance

Pietro Pepe, Ludovica Pepe, Marinella Tamburo, Giulia Marletta, Michele Pennisi, Filippo Fraggetta

Archivio Italiano di Urologia e Andrologia 2023
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification

Matteo Ferro, Bernardo Rocco, Martina Maggi, Giuseppe Lucarelli, Ugo Giovanni Falagario, Francesco Del Giudice, Felice Crocetto, Biagio Barone, Evelina La Civita, Francesco Lasorsa, Antonio Brescia, Michele Catellani, Gian Maria Busetto, Octavian Sabin Tataru, Daniela Terracciano

Expert Review of Molecular Diagnostics 2023 23 12
Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy

Guang Xu, Jun-Heng Li, Li-Hua Xiang, Bin Yang, Yun-Chao Chen, Yi-Kang Sun, Bing-Hui Zhao, Jian Wu, Li-Ping Sun, Hui-Xiong Xu

Asian Journal of Andrology 2023 25 3
A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer

Hanting Wu, Yanling Wu, Peijie He, Juan Liang, Xiujuan Xu, Conghua Ji, Sebastien Kenmoe

PLOS ONE 2024 19 2
Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects

Yutong Liu, Koji Hatano, Norio Nonomura

The World Journal of Men's Health 2024 42
Prostate Cancer

Vesna Coric, Tatjana Djukic

2024

PreviousNext

In this issue

In Vivo

Vol. 34, Issue 1

January-February 2020

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 2 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

PIETRO PEPE, GIUSEPPE DIBENEDETTO, LUDOVICA PEPE, MICHELE PENNISI

In Vivo Jan 2020, 34 (1) 393-396; DOI: 10.21873/invivo.11786

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

PIETRO PEPE, GIUSEPPE DIBENEDETTO, LUDOVICA PEPE, MICHELE PENNISI

In Vivo Jan 2020, 34 (1) 393-396; DOI: 10.21873/invivo.11786

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

prostate cancer
MRI
SelectMDx
Active surveillance

Main menu

User menu

Search

Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords